Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
We have reaffirmed our Neutral recommendation on Enbridge Energy Partners L.P. ( EEP - Analyst Report ) on January 3, 2013, based on its complimentary position to reap benefits from its partnership’s diversified business portfolio and stable fee-based operating income. However, a depressed natural gas price environment is expected to weigh on the stock. The company holds a Zacks Rank #3, which is equivalent to a short-term Hold rating.
Why Maintained?
Enbridge Energy Partners is a master limited partnership, engaged in the gathering, processing and transmission of natural gas and crude oil. The partnership is best known for its ownership of the Lakehead System, one of the world’s longest petroleum pipeline systems, which transfers over 60% of the Canadian oil output into the U.S. This unique position helps the partnership to capitalize on the growing Canadian oil sands production.
The partnership has more than $3 billion worth of organic growth projects lined up for the next two years, focused on natural gas liquids (NGLs) and crude oil. The projects –majority of which will be productive in 2013 – are driven by the sharp rise in liquids drilling from prolific shale plays in the U.S., including the Bakken Expansion, Border to Flanagan Expansion, Cushing Terminal Expansion and the Texas Express NGL pipeline.
Moreover, the Texas Express Line, expected to come online by second quarter 2014, will facilitate the transfer of additional NGL volume to Mont Belvieu. We believe these projects will lead to distribution growth, which is projected at 2–5%, over the next couple of years.
The partnership’s $1.7 billion capex budget for 2012 mainly comprises 70% Liquids and 30% Natural Gas projects.
However, Enbridge’s midstream natural gas business is sensitive to changes in natural gas supply, demand fundamentals and commodity cycles associated with gas processing margins.
Its Marketing segment reported a loss of $1.2 million in the third quarter due to weak natural gas pricing and narrower natural gas basis differentials. Furthermore, through the expansion of its natural gas gathering and processing business, Enbridge has increased its risk exposure to commodity prices.
No earnings momentum has been witnessed for the stock over the last 7 days for the fourth quarter of 2012 and for the full year 2012. The Zacks Consensus Estimates for the fourth quarter and for the full-year 2012 is currently pegged at 26 cents per share and $1.06 per share, reflecting a year-over-year decrease of 18.8% and 23.7%, respectively.
Other Stocks to Consider
While we prefer to remain on the sidelines for Enbridge, there are other stocks in the sector that appear rewarding. These include Cabot Oil & Gas Corp ( COG - Analyst Report ) and Lone Pine Resources Inc. ( LPR - Snapshot Report ) , which are expected to perform impressively over the next few months and carry a Zacks Rank #1 (Strong Buy).
Read the full reports :
Analyst Report on COG
Analyst Report on EEP
Snapshot Report on LPR